Arkolith/Insider Trading/BNKL/Form 4

Auberton-Herve Andre-Jacques

DirectorBionik Laboratories Corp. (BNKL) · full profile →Form 4 · filed Jun 21, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 13, 2023Conversion(C)186K$0.60$112K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 13, 2023Buy(P)1$220000.00$220K1

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-073231) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML